No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
253 |
4. Check minimum number of eventsNone |
253 |
5. Include endpointsNone |
253 |
6. Filter based on genotype QC (FinnGen only) |
248 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Ductal carcinoma of pancreas
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of pancreas, including Hilmo
- Solid cancers, helper endpoint
- Malignant neoplasm
- Any event in cancer register
- Malignant neoplasm, wide definition for exclusion
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 248 | 108 | 140 |
| Unadjusted period prevalence (%) | 0.05 | 0.04 | 0.06 |
| Median age at first event (years) | 69.03 | 69.84 | 68.41 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 253
- Matched controls
- 2530
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H02AB02
ATC
dexamethasone; systemic
414.7
307.7
168
12
A09AA02
ATC
multienzymes (lipase, protease etc.); oral
302.8
307.7
170
17
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
283.7
292.7
140
11
130
Kela drug reimbursment
Malignant tumour
+∞
289.3
219
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
232.8
186
*
Z51.5
ICD-10 Finland
Palliative care
73.5
231.4
137
40
A03FA01
ATC
metoclopramide; systemic, rectal
49.5
222.6
197
168
WX302
NOMESCO Finland
Thoracal epidural anesthesy
108.4
215.0
114
19
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
461.7
176.4
158
9
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
169.4
143
*
8500/3-C25.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of pancreas, NOS
+∞
165.3
140
*
JLC30
NOMESCO Finland
Pancreatoduodenectomy
+∞
157.2
134
*
A04AA02
ATC
granisetron; systemic, transdermal
2681.2
151.1
131
*
N02AA05
ATC
oxycodone; systemic
22.7
147.4
171
213
L01BC06
ATC
capecitabine; oral
+∞
127.1
111
*
JAH01
NOMESCO Finland
Laparoscopy
40.0
125.8
82
30
JN4AD
NOMESCO Finland
Body CT examination
22.8
120.8
104
75
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
120.8
106
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
28.1
118.1
89
48
TPX10
NOMESCO Finland
Implantation of vascular injection port
60.9
111.7
64
14
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
109.5
97
*
A04AA01
ATC
ondansetron; systemic, rectal
40.9
108.3
69
23
UJK02
NOMESCO Finland
ERCP
31.3
98.8
69
30
8500/3-C25.0
ICD-O-3
Infiltrating duct carcinoma, NOS, of head of pancreas
+∞
93.7
84
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
45.7
93.3
57
16
R4190
NOMESCO Finland
Nutritional therapy
36.5
87.4
57
20
JN4CD
NOMESCO Finland
Very extensive body CT
49.1
80.5
48
12
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
35.0
80.5
53
19
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
16.8
79.0
75
62
JN4BD
NOMESCO Finland
Extensive body CT
16.7
77.1
73
60
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
74.8
68
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
72.4
66
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
466.6
71.4
68
*
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
142.7
70.2
72
7
WZC00
NOMESCO Finland
Treatment plan or consultation
8.2
63.5
156
415
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
11.3
62.2
77
94
K83.1
ICD-10 Finland
Obstruction of bile duct
139.1
61.1
63
6
R50.9
ICD-10 Finland
Fever, unspecified
8.1
54.9
97
180
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
54.1
50
*
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
102.0
52.4
56
7
B01AB10
ATC
tinzaparin; parenteral
9.6
50.7
70
97
WZC30
NOMESCO Finland
Teaching
7.8
50.2
90
168
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
90.6
47.0
51
7
C25.1
ICD-10 Finland
Malignant neoplasm: Body of pancreas
+∞
46.3
43
*
TPH07
NOMESCO Finland
Cathetrisation of artery
7.5
46.2
84
158
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
186.4
45.5
46
*
L03AA02
ATC
filgrastim; parenteral
+∞
45.2
42
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
7.2
41.5
75
139
JN3AD
NOMESCO Finland
Abdominal CT examination
7.0
39.5
73
138
A06AH03
ATC
naloxegol; oral
157.6
39.0
40
*
B01AB04
ATC
dalteparin; parenteral
12.3
37.6
40
38
B01AB05
ATC
enoxaparin; parenteral
5.1
37.5
144
517
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
81.0
37.2
41
6
XX3DW
NOMESCO Finland
Time consuming IT work
10.7
37.1
44
49
JN3BD
NOMESCO Finland
Extensive abdominal CT
7.0
36.9
67
124
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
36.3
34
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
13.0
36.2
37
33
A04AA55
ATC
palonosetron, combinations; systemic
+∞
35.2
33
*
L03AA13
ATC
pegfilgrastim; parenteral
202.1
34.7
35
*
WX402
NOMESCO Finland
General anaesthesia
5.3
34.4
94
253
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
34.1
32
*
ZX120
NOMESCO Finland
Intravenous
7.8
33.4
52
81
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
5.1
32.9
97
277
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
42.9
32.6
40
11
PHN73
NOMESCO Finland
Reconstruction of superior mesenteric or portal vein
+∞
32.0
30
*
D76
ICPC
Malignant neoplasm pancreas
+∞
30.9
29
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
29.8
28
*
C25.2
ICD-10 Finland
Malignant neoplasm: Tail of pancreas
+∞
28.7
27
*
C25.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of pancreas
+∞
28.7
27
*
A10AB05
ATC
insulin aspart; parenteral
6.2
28.6
57
114
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.4
26.9
64
150
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
104.5
26.2
28
*
K83.0
ICD-10 Finland
Cholangitis
65.1
25.6
29
5
JLC10
NOMESCO Finland
Distal pancreatectomy
+∞
25.4
24
*
TPH04
NOMESCO Finland
Cathetrisation of vein
4.0
24.9
101
357
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
24.4
23
*
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
8.5
23.9
33
44
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
22.9
23.8
34
17
A04AD12
ATC
aprepitant; systemic
+∞
22.2
21
*
JJ1CE
NOMESCO Finland
Liver, bile duct and pancreas endoscopic ultrasound examination
126.0
22.0
23
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
21.1
20
*
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
27.3
20.0
27
11
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
27.3
20.0
27
11
JMA10
NOMESCO Finland
Transabdominal total splenectomy
216.2
19.8
20
*
WW500
NOMESCO Finland
Blood transfusion
20.3
19.6
29
16
A02BC02
ATC
pantoprazole; systemic
4.8
19.2
217
1414
R10.1
ICD-10 Finland
Pain localized to upper abdomen
3.7
19.1
79
277
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
+∞
19.0
18
*
WX892
NOMESCO Finland
Monitored bed care
5.0
18.7
45
105
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
29.3
18.2
24
9
C25
ICD-10 Finland
Malignant neoplasm of pancreas
+∞
17.9
17
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.2
17.6
163
915
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
16.6
17.1
27
18
JLC40
NOMESCO Finland
Total pancreatoduodenectomy
+∞
16.9
16
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
16.9
16
*
A10AE04
ATC
insulin glargine; parenteral
4.1
16.4
53
155
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
64.3
16.0
18
*
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
170.1
15.7
16
*
N05BA06
ATC
lorazepam; systemic, sublingual
5.5
15.0
31
63
ZX122
NOMESCO Finland
Intra-arterial
+∞
14.7
14
*
1CD01, ,
NOMESCO Finland
+∞
14.7
14
*
JL1AT
NOMESCO Finland
Biopsy of pancreas with ultrasound guidance
+∞
14.7
14
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.0
14.6
85
360
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
24.0
14.5
20
9
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
79.6
13.7
15
*
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
79.6
13.7
15
*
ZXE40
NOMESCO Finland
More than seven and less than nine hours
17.5
13.7
21
13
8500/3-C25.1
ICD-O-3
Infiltrating duct carcinoma, NOS, of body of pancreas
+∞
13.7
13
*
8500/3-C25.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of tail of pancreas
+∞
13.7
13
*
R18
ICD-10 Finland
Ascites
13.3
12.9
22
18
J01MA12
ATC
levofloxacin; systemic
3.0
12.6
69
280
WX004
NOMESCO Finland
Patient-controlled sedation
+∞
12.6
12
*
JKE25
NOMESCO Finland
Endoscopic external drainage of bile duct
+∞
12.6
12
*
A79
ICPC
Malignancy NOS
+∞
12.6
12
*
JK3NB
NOMESCO Finland
Percutaneous transhepatic cholangiography
136.5
12.6
13
*
JAH00
NOMESCO Finland
Laparotomy
11.4
12.5
23
22
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
15.4
12.5
20
14
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
5.8
12.1
23
43
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
49.1
12.0
14
*
JKE22
NOMESCO Finland
Endoscopic extraction of foreign body from bile duct
+∞
11.5
11
*
WX725
NOMESCO Finland
Noninvasive ventilation
4.6
11.3
28
66
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.5
11.1
102
536
WF002
NOMESCO Finland
Radical radiotherapy
45.4
11.0
13
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.5
10.7
101
534
D70.82
ICD-10 Finland
Drug-induced neutropenia
62.7
10.7
12
*
N02AX02
ATC
tramadol; systemic, rectal
2.4
10.7
138
840
SPAT1109
SPAT
Analgesia with portable analgesic pump
114.6
10.5
11
*
115
Kela drug reimbursment
Breast cancer
+∞
10.5
10
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
10.5
10
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
10.5
10
*
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
5.1
10.5
23
49
K85.8
ICD-10 Finland
Other acute pancreatitis
34.1
10.4
13
*
R4110
NOMESCO Finland
Physiotherapy
2.5
10.4
87
435
WX704
NOMESCO Finland
Intubation
4.0
10.2
31
86
103
Kela drug reimbursment
Diabetes, insulin-treated
2.4
10.1
104
569
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
12.9
10.0
17
14
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
10.2
10.0
19
20
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
27.3
9.9
13
5
N05AD01
ATC
haloperidol; systemic
5.6
9.8
19
36
WX002
NOMESCO Finland
Sedation and analgesia
2.6
9.7
70
324
D13.6
ICD-10 Finland
Benign neoplasm: Pancreas
57.2
9.7
11
*
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
10.7
9.7
18
18
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.8
9.7
59
251
JK3NT
NOMESCO Finland
Percutaneous transhepatic dilatation of bileducts
+∞
9.4
9
*
JK4ZT
NOMESCO Finland
Percutaneous transhepatic implantation of bile duct prothesis
+∞
9.4
9
*
JL2AT
NOMESCO Finland
Cytology of pancreas with ultrasound guidance
+∞
9.4
9
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
9.4
9
*
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
5.1
9.2
20
42
WX610
NOMESCO Finland
Patient controlled analgesia
38.2
9.1
11
*
K90.3
ICD-10 Finland
Pancreatic steatorrhoea
25.1
9.0
12
5
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.3
8.8
94
517
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
8.3
8.5
18
23
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
8.4
8
*
JLC11
NOMESCO Finland
Laparoscopic distal pancreatectomy
+∞
8.4
8
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
8.4
8
*
191
Kela drug reimbursment
Erlotinib
+∞
8.4
8
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
8.4
8
*
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
8.0
8.3
18
24
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
10.5
8.1
15
15
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
46.4
7.8
9
*
R11
ICD-10 Finland
Nausea and vomiting
3.2
7.6
32
110
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
6.3
7.5
19
32
A06AD11
ATC
lactulose; oral
2.5
7.5
52
234
Z31.5
ICD-10 Finland
Genetic counselling
8.1
7.5
16
21
SPAT1255
SPAT
Intravenous administration of medicine
3.5
7.5
27
84
JKE32
NOMESCO Finland
Endoscopic dilatation of bile duct
82.4
7.5
8
*
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
82.4
7.5
8
*
C10AC01
ATC
colestyramine; oral
6.1
7.4
19
33
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
7.3
7
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
7.3
7
*
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
7.3
7
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
7.3
7
*
JLD12
NOMESCO Finland
Endoscopic drainage of pancreatic pseudocyst
+∞
7.3
7
*
C10AA07
ATC
rosuvastatin; oral
0.4
7.1
32
725
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.1
6.9
30
105
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.4
6.8
52
244
ZX090
NOMESCO Finland
Other technic of radiotherapy
41.2
6.8
8
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.6
6.6
41
175
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
4.1
6.6
18
46
J01MA02
ATC
ciprofloxacin; systemic
2.0
6.6
112
722
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
71.6
6.5
7
*
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
71.6
6.5
7
*
TPX15
NOMESCO Finland
Removal of vascular injection port
71.6
6.5
7
*
E89.1
ICD-10 Finland
Postprocedural hypoinsulinaemia
71.6
6.5
7
*
ZXE20
NOMESCO Finland
More than three and less than five hours
2.5
6.4
42
184
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
6.3
6
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
6.3
6
*
PHN72
NOMESCO Finland
Plastic repair of superior mesenteric or portal vein
+∞
6.3
6
*
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
+∞
6.3
6
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
6.3
6
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
6.3
6
*
A41.8
ICD-10 Finland
Other specified sepsis
7.0
6.1
14
21
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
10.4
6.1
11
11
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
7.5
6.0
13
18
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
207
104
104.97
303.80
9.5
1.4
12.09
2.59
ug/l
1.58
201
78
133
48
57.31
210.68
1.6
1.3
103.20
296.63
ug/g
6.72
65
29
199
658
10.48
65.76
7.5
2.2
90.03
65.14
u/l
0.63
193
611
123
276
7.73
58.47
11.9
5.8
105.20
104.13
mmol/l
1.76
123
276
99
181
8.34
56.97
9.3
2.0
407.26
32.19
u/l
0.59
90
150
216
1043
8.32
40.14
15.6
15.3
1.25
1.35
inr
0.94
50
280
41
9
54.03
34.97
1.2
1.1
—
—
—
0
0
65
124
6.71
34.59
1.6
1.5
—
—
—
0
0
188
894
5.29
32.75
4.2
2.3
—
—
—
0
0
208
1074
6.27
32.62
37.2
5.9
3.89
4.32
e9/l
2.38
188
933
93
259
5.10
32.46
10.9
6.9
1.43
1.63
mmol/l
0.20
85
208
36
7
59.60
31.26
1.4
1.1
3.18
5.39
nmol/l
—
36
7
86
239
4.94
29.82
2.0
1.8
—
—
—
0
0
85
239
4.85
28.96
2.0
1.8
—
—
—
0
0
102
332
4.47
28.77
2.0
1.7
—
—
—
0
0
150
648
4.23
28.49
12.2
2.0
2.30
2.35
mmol/l
3.78
144
532
183
937
4.44
26.69
10.4
5.2
1.17
1.21
mmol/l
6.26
176
839
60
134
5.56
26.65
9.6
8.4
0.76
0.71
%
0.31
60
134
60
137
5.43
25.96
9.5
8.4
1.63
1.49
%
0.30
60
137
188
1025
4.25
24.01
10.7
5.7
1.18
1.21
mmol/l
6.60
164
902
84
271
4.14
23.37
1.8
2.3
14.15
24.21
%
11.52
67
233
92
323
3.90
22.62
2.0
2.2
8.43
13.45
umol/l
12.95
92
297
93
333
3.83
22.15
2.1
1.8
30.39
29.43
s
0.84
93
320
103
449
3.18
17.29
3.5
2.1
—
—
—
0
0
43
107
4.64
16.45
8.0
7.4
26.11
25.60
mmol/l
0.49
43
107
35
74
5.33
16.20
8.6
4.5
3.80
3.95
mmol/l
1.38
35
74
45
132
3.93
13.78
1.8
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
29
62
5.15
13.19
3.1
2.6
0.20
0.42
u/ml
3.48
13
32
54
187
3.40
12.89
6.7
6.2
1.38
1.43
mmol/l
0.12
54
182
27
58
5.09
12.20
2.0
1.6
—
—
—
0
0
127
741
2.43
10.90
3.8
2.9
—
—
—
0
0
103
553
2.45
10.56
3.4
2.7
0.36
0.43
e6/l
0.24
79
396
15
8
19.83
10.39
1.7
1.5
16.74
12.91
ug/l
—
15
8
23
52
4.77
9.77
1.1
1.3
—
—
—
0
0
18
37
5.16
8.50
1.1
1.3
—
—
—
0
0
18
37
5.16
8.50
1.1
1.2
—
—
—
0
0
17
24
7.51
7.62
1.3
1.3
—
—
—
0
0
12
10
12.52
7.15
1.7
1.3
24.83
28.80
umol/l
—
12
10
179
2131
0.45
7.07
3.6
4.9
1.39
1.45
mmol/l
0.83
163
1942
181
2146
0.45
7.06
3.7
5.0
4.26
4.52
mmol/l
2.46
168
1964
188
2196
0.44
6.96
4.1
5.6
2.43
2.64
mmol/l
2.27
171
2003
89
531
2.04
6.45
2.1
2.1
3.10
3.23
mg/l
0.19
83
445
31
119
2.83
6.07
2.1
2.3
0.81
0.61
%
1.43
31
119
17
36
4.99
5.73
4.8
3.1
5.47
5.09
kpa
1.35
17
36
31
123
2.73
5.71
2.1
2.3
1.49
1.17
%
0.62
31
123
174
2061
0.50
5.70
3.4
4.4
1.31
1.30
mmol/l
0.01
159
1865
45
219
2.28
5.40
3.0
3.0
5.75
5.79
kpa
0.10
45
211
61
341
2.04
5.15
3.5
2.8
2.99
2.31
e6/l
0.16
30
177
82
512
1.89
5.02
4.3
3.9
0.00
0.00
estimate
-0.00
24
149
63
360
2.00
5.00
3.3
2.6
0.87
1.13
e6/l
0.47
32
195
13
26
5.21
4.70
1.1
1.2
—
—
—
0
0
30
130
2.48
4.64
2.0
1.6
—
—
—
0
0
43
219
2.16
4.61
3.2
3.0
2.61
2.20
mmol/l
0.33
36
185
12
23
5.42
4.51
1.1
1.2
—
—
—
0
0
38
186
2.23
4.48
3.0
2.6
4.43
4.60
kpa
0.15
38
177
73
458
1.83
4.32
4.1
4.1
114.60
288.07
ng/l
0.85
65
379
166
1954
0.56
4.31
3.7
4.6
1.99
2.01
mu/l
0.10
151
1762
12
25
4.98
4.24
1.2
1.2
—
—
—
0
0
131
977
1.71
4.22
5.2
5.1
0.00
0.00
estimate
-0.00
25
153
13
32
4.22
3.96
1.2
1.2
—
—
—
0
0
191
2151
0.54
3.96
4.6
5.0
6.50
6.09
mmol/l
3.77
185
1944
132
999
1.67
3.93
4.1
3.7
0.00
0.00
estimate
-0.00
25
149
8
11
7.47
3.89
1.1
1.4
—
—
—
0
0
8
12
6.84
3.70
1.0
1.0
—
—
—
0
0
9
16
5.79
3.69
1.1
1.3
—
—
—
0
0
128
974
1.64
3.64
4.1
3.7
0.00
0.01
estimate
0.50
29
163
10
21
4.91
3.59
1.1
1.2
—
—
—
0
0
10
21
4.91
3.59
1.1
1.2
—
—
—
0
0
6
6
10.20
3.51
1.3
1.8
—
—
—
0
0
10
23
4.48
3.34
1.2
1.2
—
—
—
0
0
10
26
3.96
3.01
1.1
1.2
—
—
—
0
0
10
26
3.96
3.01
1.1
1.2
—
—
—
0
0
101
751
1.57
3.01
4.6
3.9
—
—
—
0
0
5
5
10.16
2.99
1.4
1.0
—
—
—
0
0
13
48
2.80
2.76
1.2
1.2
—
—
—
0
0
67
462
1.61
2.70
4.3
4.0
1.02
1.02
kg/l
0.16
12
66
11
37
3.06
2.52
1.5
1.4
—
—
—
0
0
11
37
3.06
2.52
1.5
1.4
—
—
—
0
0
133
1568
0.68
2.37
3.2
3.8
15.22
14.94
pmol/l
0.62
120
1409
8
23
3.56
2.29
1.0
1.3
—
—
—
0
0
6
13
4.70
2.28
1.0
1.2
—
—
—
0
0
6
13
4.70
2.28
1.0
1.2
—
—
—
0
0
6
13
4.70
2.28
1.0
1.2
—
—
—
0
0
115
920
1.46
2.27
4.0
3.8
17.99
78.92
ng/l
1.07
91
687
181
2000
0.67
2.14
47.1
11.9
84.41
76.16
ml/min/173m2
7.15
167
1613
12
49
2.52
2.14
1.6
1.1
—
—
—
0
0
11
44
2.57
2.04
1.2
1.4
—
—
—
0
0
8
26
3.14
2.03
1.1
1.2
—
—
—
0
0
32
197
1.71
1.98
6.9
3.0
—
—
—
0
0
0
54
0.00
1.87
0.0
1.2
—
—
—
0
0
104
840
1.40
1.86
2.4
2.2
64.97
77.11
nmol/l
3.94
98
726
37
541
0.63
1.84
2.3
2.7
0.79
0.71
ug/l
0.18
26
364
7
26
2.74
1.59
4.7
3.0
63.14
58.08
%
—
7
26
6
142
0.41
1.58
1.2
1.9
—
—
—
0
0
221
2316
0.64
1.47
74.2
19.2
35.18
40.50
%
22.42
200
2132
7
28
2.54
1.46
1.0
1.0
2.01
1.50
g/l
—
7
23
7
28
2.54
1.46
1.6
1.1
—
—
—
0
0
25
158
1.65
1.44
2.0
1.8
85.97
63.61
ml/min/173m2
—
6
59
6
24
2.54
1.31
1.0
1.0
—
—
—
0
0
6
24
2.54
1.31
1.8
1.0
—
—
—
0
0
8
36
2.26
1.25
1.9
2.6
106.00
105.11
mmol/l
—
8
36
6
25
2.43
1.25
1.8
1.0
—
—
—
0
0
8
38
2.14
1.19
1.6
1.3
—
—
—
0
0
0
33
0.00
1.17
0.0
1.2
—
13.00
—
0
14
7
137
0.50
1.13
1.1
1.4
—
33.48
—
0
12
0
30
0.00
0.98
0.0
1.1
—
—
—
0
0
6
28
2.17
0.92
1.3
1.4
—
—
—
0
0
198
2084
0.77
0.91
7.4
6.5
43.99
40.58
mmol/mol
3.75
192
1917
53
435
1.28
0.80
1.6
1.7
1477.69
1189.42
nmol/l
1.38
46
329
13
82
1.62
0.79
1.3
1.3
—
—
—
0
0
86
978
0.82
0.78
3.8
3.9
2.26
1.94
ug/l
0.49
78
873
0
27
0.00
0.78
0.0
1.1
—
1.25
—
0
8
38
302
1.30
0.73
25.3
7.5
—
—
—
0
0
7
39
1.82
0.73
1.0
1.3
—
—
—
0
0
5
25
2.02
0.73
2.0
1.0
—
—
—
0
0
5
25
2.02
0.73
2.0
1.0
—
—
—
0
0
5
25
2.02
0.73
2.0
1.0
—
—
—
0
0
5
25
2.02
0.73
1.6
2.0
—
—
—
0
0
5
25
2.02
0.73
2.0
1.0
—
—
—
0
0
12
76
1.61
0.73
2.0
3.4
—
—
—
0
0
5
28
1.80
0.66
2.8
1.3
75.00
62.04
pmol/l
—
5
28
5
29
1.74
0.64
1.2
1.0
—
—
—
0
0
10
63
1.61
0.62
1.1
1.2
—
—
—
0
0
11
72
1.55
0.60
1.6
1.4
—
—
—
0
0
8
52
1.56
0.60
1.5
1.7
—
—
—
0
0
0
22
0.00
0.59
0.0
1.3
—
160.97
—
0
22
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
0
23
0.00
0.58
0.0
2.1
—
—
—
0
0
84
750
1.18
0.57
2.2
3.1
805.82
1238.15
ng/l
1.10
76
643
9
63
1.44
0.53
1.1
1.2
—
—
—
0
0
11
76
1.47
0.49
1.6
1.5
—
—
—
0
0
71
783
0.87
0.42
4.2
3.8
20.35
24.28
%
1.51
33
359
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
54
606
0.86
0.40
1.8
1.7
1.25
1.34
mmol/l
0.29
47
501
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
6
42
1.44
0.36
1.0
1.2
—
—
—
0
0
220
2242
0.86
0.31
61.7
15.5
69.76
80.39
umol/l
9.96
220
2242
111
1057
1.09
0.25
2.9
2.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
152.77
—
0
11
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
266.00
—
0
5
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
1.07
—
0
7
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
2.4
—
48.22
—
0
9
16
185
0.86
0.19
1.1
1.3
—
—
—
0
0
159
1552
1.07
0.16
2.8
4.3
17.92
12.00
mm/h
3.75
150
1408
17
150
1.14
0.15
1.5
3.9
4.56
5.20
kpa
2.56
17
145
7
86
0.81
0.15
1.4
1.6
—
132.00
—
0
5
42
393
1.08
0.14
1.3
1.2
9.47
1.57
u/ml
0.42
14
108
69
719
0.94
0.12
1.8
2.2
184.00
188.63
u/l
0.03
64
668
6
58
1.04
0.08
1.3
1.6
—
—
—
0
0
5
64
0.78
0.08
1.2
1.3
—
—
—
0
0
6
72
0.83
0.07
1.7
1.3
1.08
1.17
g/l
—
6
67
22
234
0.93
0.07
1.4
1.4
—
—
—
0
0
80
818
0.97
0.06
3.1
3.8
7.45
7.92
mg/mmol
0.05
54
504
20
210
0.95
0.04
1.3
1.9
1.38
1.67
%
0.93
15
175
95
958
0.99
0.01
2.1
2.0
89.98
95.54
pmol/l
0.69
75
492
14
141
0.99
0.00
1.6
4.0
1.50
2.19
mmol/l
—
6
106
8
79
1.01
0.00
1.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
9.51
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
6.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
2291.60
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
68
0.88
-0.00
1.7
1.4
0.26
0.23
g/l
—
6
63
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_PANCREAS_DUCTAL – Ductal carcinoma of pancreas
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).